The Scientist - Home

Paul Cohen of the Rockefeller University describes his study of thousands of people, finding that the energy-burning tissue is tied to a lower risk of for several diseases, including type 2 diabetes, high blood pressure, and heart disease.

Zoo officials say the captive primates are recovering, but scientists worry the virus could spread quickly through dwindling wild populations.

A widely publicized paper has drawn scrutiny from physicians and anatomists about the authors’ claims regarding so-called tubarial glands.  

The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.

From new treatments to an investigation into the virus’s origins, here are some of the developments we can expect this year.

An engineered coronavirus with the N501Y mutation—one of many mutations present in the emerging B.1.1.7 and 501.V2 variants of the coronavirus—is neutralized by the sera of COVID-19 vaccine recipients.

Governments are variable in their reliance on highly cited research, while international intergovernmental organizations such as the World Health Organization reliably link policy and science, according to an analysis of thousands of policy documents from the first half of 2020.

The majority of people experiencing anaphylaxis had a history of allergic reactions, a report by the agency finds.

From immigration reform to climate change amelioration, researchers and science policy advocates share their hopes for 2021 and beyond.

DNA replication errors during cell division cause monozygotic twins to diverge from each other even during the earliest stages of development, a new study finds.

Their relocation explains horizontal genome transfer first described more than a decade ago.

An analysis of data from nearly 150 journals across scientific disciplines finds that, if anything, manuscripts authored by women are treated more favorably than those submitted by men.